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et al.,1995). In the case of Raf-1, this interaction appearsDepartment of Medicine
to be functional; overexpression or microinjection of 14-Jewish Hospital
3-3 into fibroblast cells or Xenopus laevis oocytes, re-²Department of Cell Biology and Physiology
spectively, results in Raf-1 activation (Fantl et al., 1994;Washington University School of Medicine
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Given the large and diverse numbers of proteins that³Center for Immunology and Department of Pathology
can apparently bind 14-3-3, it is important to determineWashington University School of Medicine
the nature of 14-3-3 binding interactions. Unfortunately,St. Louis, Missouri 63110
little is currently known about how 14-3-3 interacts with
other proteins. Because Raf-1 and protein kinase C both
have zinc-finger-like domains, it has been suggested
Summary
that 14-3-3 binds to zinc-finger sequences (Freed et al.,
1994). In support of this, it was recently shown that
The highly conserved and ubiquitously expressed 14- mutation of two critical cysteine residues in the first
3-3 family of proteins bind to a variety of proteins zinc-finger domain of Raf-1 abrogates its ability to bind
involved in signal transduction and cell cycle regula- 14-3-3 (Michaud et al., 1995). However, as many other
tion. The nature and specificity of 14-3-3 binding is, known 14-3-3 binding proteins do not contain zinc-fin-
however, not known. Here we show that 14-3-3 is a ger-like domains, it seems unlikely that 14-3-3 binds
specific phosphoserine-binding protein. Using a panel only to such domains. Another common physical feature
of phosphorylated peptides based on Raf-1, we have must therefore account for most, if not all, 14-3-3 inter-
defined the 14-3-3 binding motif and show that most actions.
of the known 14-3-3 binding proteins contain themotif. Several observations suggest that 14-3-3 interactions
Peptides containing the motif could disrupt 14-3-3 involve binding to phosphoserine. First, the 14-3-3 acti-
complexes and inhibit maturation of Xenopus laevis vation of tyrosine hydroxylase requires prior phosphory-
oocytes. These results suggest that the interactions lation of tyrosine hydroxylase with the serine/threonine
of 14-3-3 with signaling proteins are critical for the kinase calmodulin kinase II (Furukawa et al., 1993). Sec-
activation of signaling proteins. Our findings also sug- ond, phosphatase treatment of Raf-1 and bcr inhibits
gest novel roles for serine/threonine phosphorylation their association with 14-3-3 in vitro (Michaud et al.,
1995). Lastly, 14-3-3 binding to Raf-1 can block thein the assembly of protein±protein complexes.
ability of phosphatases to inhibit Raf-1 activity (Dent et
al., 1995). Together, these data suggest that binding toIntroduction
phosphoserine could account for a large number of the
reported 14-3-3 interactions. Furthermore, 14-3-3 may
bind to phosphoserine in a sequence-specific manner.The 14-3-3 proteins are ubiquitous proteins that were
This would imply that 14-3-3 could function in a mannerfirst discovered as abundant, acidic proteins in the brain
analogous to SH2 domains (reviewed by Pawson [1995]).(reviewed in Aitken, 1995). They are broadly expressed
Similar to SH2 domains that bind to phosphotyrosine in
in a wide range of eukaryotic organisms including yeast,
a sequence-specific manner, 14-3-3 binding to specific
plants, and man. Members of the 14-3-3 family of pro-
phosphoserine-containing motifs could result in the as-
teins are highly related, and at least seven different iso-
sembly of important signaling complexes as suggested
forms have been identified in mammalian cells. In both by Braselmann and McCormick (1995). The plausibility
budding and fission yeast, the 14-3-3 genes are known of such a hypothesis will first require an analysis of the
to be essential genes; yeast with disruption of their 14- binding specificity of 14-3-3.
3-3 genes are nonviable (Gelperin et al., 1995).
Although the exact function of 14-3-3 is not known, Results
numerous biological activities have been attributed to
14-3-3. 14-3-3 was first implicated as an activator of the Direct Binding of 14-3-3z to a
neuronal enzyme tyrosine hydroxylase (Ichimura et al., Serine-Phosphorylated Raf-1 Peptide
1988). It can also bind and regulate the activity of protein Recent work by Morrison and coworkers demonstrated
kinase C (Toker et al., 1990; Isobe et al., 1992; Tanji et that theserine residue atposition 259 of Raf-1 is required
al., 1994). It is a required cofactor for the bacterial toxin for 14-3-3 binding (Michaud et al., 1995). Because these
of Pseudomonas, an ADP ribosylase known as exoen- data suggest that 14-3-3 is a phosphoserine-binding
zyme S (Fu et al., 1993), and has been implicated in cell protein, we began by testing whether 14-3-3 could bind
cycle control (Ford et al., 1994). More recently, with the directly to phosphoserine-containing peptides.
advent of the yeast two-hybrid system, 14-3-3 has been A peptide containing Raf-1 sequences surrounding
found to bind to a number of important signaling pro- serine 259 of Raf-1 (residues 252±264, designated Raf-
teins, including Raf-1, polyoma middle T antigen, bcr, 259; see Figure 2A) was synthesized and phosphory-
lated in vitro using protein kinase A (PKA) and [g-32P]ATP.and PI-3 kinase (Fantl et al., 1994; Freed et al., 1994; Fu
Cell
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For these experiments, we used a 14-3-3z/glutathione
S-transferase (GST) fusion protein immobilized to gluta-
thione agarose beads. After incubation of the labeled
peptide with immobilized 14-3-3z fusion protein, binding
of the labeled peptide was measured. The labeled phos-
phorylated peptide bound to the 14-3-3z-coupled beads
but not to the glutathione beads alone (Figure 1A). Bind-
ing was specific for phosphoserine because it could be
competed with phosphorylated peptide but not with the
unphosphorylated peptide. It also appeared to be se-
quence specific. Competition with free phosphoserine
or a threonine phosphorylated casein kinase II substrate
peptide (RRREEEpTEEE) did not compete for binding
nor did a tyrosine phosphorylated peptide (pYEEIQPAK).
The interaction was also of high affinity; competitive
inhibition demonstrated an IC50 of z1±2 mM (Figure 1B).
As the calculated stoichiometry of in vitro phosphoryla-
tion of the peptide ranged between 7% and 12%, the
true IC50 was z70±240 nM.
Surface plasmon resonance (SPR) was used to di-
rectly measure the affinity of the interaction of 14-3-3z
for the Raf-1 peptide. This method detects binding in
real time and allows the rates of association (kon) and
dissociation (koff) to be determined directly. The unphos-
phorylated Raf-1 peptide was attached to the sensor
surface and tested for its ability to bind 14-3-3z. As
expected, no significant binding of 14-3-3z to the un-
phosphorylated peptide was observed (Figure 1C). The
peptide was then phosphorylated in situ by infusing PKA
and ATP over the surface of the sensor chip. Reinjection
of 14-3-3z over the sensor surface now clearly demon-
strated binding (Figure 1C). This was specific to the 14-
3-3 moiety, as GST alone did not bind to either the
unphosphorylated or phosphorylated peptide (data not
shown). Kinetic measurements (Figure 2B) demon-
strated that the association rate was z2.3 3 104 M21 3
s21 and the dissociation rate was approximately 2.8 3
1023 s21. To minimize the effects of protein rebinding to
the surface of the sensor chip, the dissociation rate was
measured in the presence of 50 mM free phosphorylated
Raf-1 peptide. Given that the equilibrium dissociation
constant, KD can be determined by KD 5 koff/kon, the
apparent KD measured by SPR is z122 nM.
Figure 1. 14-3-3 Protein Binds Specifically to Serine-Phosphory-
lated Raf-1 PeptideThe Binding of 14-3-3z to the
(A) Specific binding of 14-3-3z to phosphorylated Raf-259 peptide.Serine-Phosphorylated Raf-1 Peptide
Raf-259 peptide was phosphorylated in vitro using the catalyticIs Sequence Specific
subunit of PKA in the presence or absence of [g-32P]ATP. Radiola-To determine the sequence specificity of the interaction,
beled phosphorylated Raf-259 peptide (5 mM) was added to immobi-
we synthesized a series of phosphopeptides and tested lized GST/14-3-3z in the presence of different concentrations of
each as competitive inhibitors of 14-3-3z binding to the nonradiolabeled phosphorylated or unphosphorylated peptides.
phosphorylated Raf-259 peptide (Figure 2). Each of the After washing, bound radiolabeled peptide was measured by scin-
tigraphy. Key: cold phospho-259, phosphorylated nonradiolabeledpeptides was purified by high pressure liquid chroma-
Raf-259 peptide; unphospho-259, unphosphorylated nonradiola-tography, and the integrity of each peptide was con-
beled Raf-259 peptide; phospho-ETEE, phosphorylated casein ki-firmed by massspectroscopy. As theRaf-1 peptide used
nase II substrate peptide; phospho-YEEI, tyrosine phosphorylated
peptide, pYEEISPAK.
(B) Competitive binding of phosphorylated Raf-1 peptides to 14-
3-3. GST/14-3-3z was immobilized on agarose beads. Radiolabeled
Raf-259 peptide (1 mM) was added to immobilized GST/14-3-3z into a strepavidin-coated sensor chip. GST/14-3-3z (1 mM) was then
the presence of various concentrations of nonradiolabeled phos-infused over the surface at a flow rate of 5 ml/min for 5 min (2
phorylated Raf-259 peptide. Bound radiolabeled peptide was mea-phosphorylation). The bound peptides were then phosphorylated
sured by scintigraphy.by infusing PKA (0.5 U/ml) with 200 mM ATP for 25 min at 308C.
(C) 14-3-3 binds specifically to phosphorylated but not to unphos-GST/14-3-3z (1 mM) was then reinfused for 5 min at 5 ml/min (1
phorylated Raf-1 peptide. Biotinylated Raf-259 peptide was boundphosphorylation).
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provide only a relative affinity for the different peptides
used (Payne et al., 1993).
The pS-Raf-259 peptide competed with an IC50 of z6
mM (Figures 2C and 2D). In contrast, the pS-Raf-257
peptide and the pS-Raf-257,259 peptide demonstrated
little, if any, inhibition at the highest concentration
tested, 50 mM (Figures 2C and 2D). This confirms that
phosphorylation of serine 259 is critical for 14-3-3z bind-
ing. Furthermore, the inability of the pS-Raf-257,259
peptide to bind suggests that the serine at position 257
is also important. As the only difference between pS-
Raf-257 and pS-Raf-259 peptides is the position of the
phosphoserine, high affinity binding of 14-3-3z to serine
phosphate is exquisitely sequence specific.
To further define the binding motif, we looked for se-
quences similar to the amino acids surrounding serine
259 in otherproteins known tobind 14-3-3. Interestingly,
CDC25 shares the motif RxRSxSxP (where X 5 any
amino acid) while polyoma middle T contains a slightly
shorter version of the motif (RSxSxP). Surprisingly, Raf-
1 contains both instances of the motif, at positions 256±
261 and 618±623 respectively; both are known to be
phosphorylation sites in vivo (Morrison et al., 1993). This
suggested that the binding motif might be related to the
sequence RxRSxpSxP.
The importance of the arginine residues in defining
the 14-3-3z binding motif was tested by synthesizing
phosphopeptides with alanines substituted for either or
both arginines (254/256RA, 254RA, 256RA; Figure 2A).Figure 2. Affinity Data for 14-3-3 Isoform Binding to Serine Phos-
The peptide with alanine substituted for both argininesphorylated Peptides
(254/256RA) exhibited no detectable inhibition at con-(A) List of peptides used. The complete amino acid sequence of
centrations up to 50 mM, demonstrating that one or botheach peptide is given using the one-letter amino acid code. The
arginine residues are critical for binding (Figure 2D). Theposition of the phosphorylated serine is bolded and designated, pS.
Key residues that were changed are underlined. 254RA peptide competed almost as efficiently as wild-
(B) Calculated on (kon) and off (koff) rates for 14-3-3z, h, b, and t type (9 mM), while the 256RA peptide competed much
binding to phosphorylated Raf-259 peptide. Biotinylated wild-type less efficiently. Although this demonstrated that theargi-
Raf-259 peptide was coupled to avidin-coated sensor chip surface
nine in position 23 from the phosphoserine is criticaland phosphorylated in situ using PKA. SPR was used to measure
for binding, the inability of the alanine substitution atkon and koff. koff rates were calculated in the presence of 50 mM
25 to completely abrogate binding suggested that basicfree pS-Raf-259 peptide. The apparent KD was calculated from the
residues in other positions might also contribute to theequation KD 5 kdiss/kass.
(C) 14-3-3 isoforms exhibit similar binding affinities and specificities. binding affinity. The relative affinities of two additional
14-3-3 fusion proteins (0.5±1 mM) were preincubated with various peptides with the arginine placed in the 22 or 24 posi-
peptides at concentrations between 1 and 50 mM. They were then tions were therefore analyzed. The peptide with arginine
infused across a sensor chip surface that had been previously cou-
in the 22 position did not compete for binding at thepled with the phosphorylated Raf-259 peptide. IC50 values were
highest concentration tested (50 mM), confirming thatdetermined by plotting the concentration of competitor peptide re-
the position of the arginine residue is clearly important.quired to achieve a 50% reduction in equilibrium binding.
However, the peptide with arginine in the 24 position(D) Competitive inhibition with wild-type and mutated Raf-1 pep-
tides. GST/14-3-3z was preincubated with peptides at concentra- competed almost as well as the peptide with arginine
tions between 1 mM and 50 mM and the IC50 values calculated as in the 23 position. We conclude that an arginine residue
described in (C). is required in the 23 and/or 24 position from the phos-
phorylated serine.
above (residues 252±264) contains potential PKA phos- To determine the importance of the proline residue,
phorylation sites at positions 257 and 259, we first another phosphorylated peptide with alanine substi-
needed to confirm that serine 259 was the critical phos- tuted for proline (PA) was generated. The PA peptide
phorylated residue. Raf-259 peptides were therefore demonstrated an IC50 of z25 mM, confirming that the
synthesized with phosphoserines at positions corre- proline residue is important but also suggesting that this
sponding to position 257 (pS-Raf-257), 259 (pS-Raf- position may tolerate other residues (Figures 2C
259), or both 257 and 259 (pS-Raf-257,259). The ability and 2D).
of each peptide to inhibit binding of 14-3-3z to the phos- To determine whether other predicted sequences
phorylated peptide was then tested in a range of con- containing the motif could bind 14-3-3, we tested a
centrations between 1 and 50 mM. Because concentra- phosphopeptide corresponding to Raf-1 residues 613±
tions of 14-3-3 were required (500±1000 nM) to reach 627 (pS-Raf-621; Figure 2). The IC50 of this peptide was
equilibrium binding that were much higher than the ap- z1 mM. The ability of the phosphorylated Raf-621 pep-
tide to bind at high affinity confirmed that the motif canparent KD (100±150 nM), the IC50 values that we derived
Cell
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Table 1. Use of Positional Degenerate Peptides to Identify Critical Binding Residues
Competitor Peptide Sequence Binding (%)a
No peptide — 100
pS-Raf-621 L P K I N R S A pS E P S L H R ,5
25 L P K X N R S A pS E P S L H R ,5
23 L P K I N X S A pS E P S L H R 17
22 L P K I N R X A pS E P S L H R 27
21 L P K I N R S X pS E P S L H R ,5
11 L P K I N R S A pS X P S L H R ,5
12 L P K I N R S A pS E X S L H R 56
Identification of critical motif residues using degerate peptides. The sequences of the degenerate peptide pools are given using the one-letter
amino acid code. X 5 all 20 amino acids. Each of the peptides was tested as an inhibitor (at 10 mM) in a binding assay using SPR. Peptides
were preincubated with GST/14-3-3z (1 mM) and then infused over a Biacore sensor chip coated with the phosphorylated Raf-259 peptide.
a At 10 mM.
be used to predict other proteins that bind 14-3-3. As affinities to this peptide. Competitive inhibition with the
mutated phosphorylated Raf-1 peptides was used tothis latter peptide contains only one of the two N-termi-
nal arginine residues, the minimal binding sequence for determine whether their specificities were similar (Figure
2C). In each case, the calculated IC50s were very similar14-3-3z is RSxpSxP.
to those calculated for 14-3-3z. All four 14-3-3 isoforms
exhibited little to no affinity toward the RA peptide andConfirming the Critical Motif Residues
Using Degenerate Peptides intermediate affinities toward the PA peptide. These re-
sults suggest that the binding affinity and sequenceA series of degenerate peptides were synthesized to
confirm that the arginine in the 23 position, the serine specificity of multiple 14-3-3 isoforms for serine phos-
phorylated peptides are very similar.in the 22 position, and the proline in the 12 position
were the critical motif residues (Table 1). Six pools of
peptides were synthesized with all 20 amino acids 14-3-3 Can Block Dephosphorylation
of Raf-1placed in positions 25, 23, 22, 21, 11, and 12, respec-
tively. Each pool of 20 peptides was tested as competi- To confirm that 14-3-3 physically contacts the phospho-
serine residue, we tested whether addition of 14-3-3tive inhibitors for binding. We reasoned that if a particu-
lar position is not critical for binding, the pool of 20 could block the ability of the serine/threonine phospha-
tase PP1 to dephosphorylate Raf-1. A GST/Raf-1 fusionpeptides should compete as well as wild-type peptide
for binding. On the other hand, if a particular amino acid protein was phosphorylated in vitro with PKA and
[g-32P]ATP. Phosphorylated Raf-1 was then incubatedis required at a particular position, only a small fraction
of the pool will be able to compete for binding, thus with PP1 in the presence or absence of 14-3-3 (Figure
3). Consistent with results reported by Dent et al. (1995),increasing (up to 20-fold) the concentration of peptide
needed to inhibit binding. Pools with degenerate amino incubation of phosphorylated Raf-1 with 14-3-3 com-
pletely blocked the ability of PP1 to dephosphorylateacids in positions 25, 21, and 11 competed as well as
wild-type, demonstrating that these positions are not Raf-1. This was specific to 14-3-3 because addition of
a control protein had no effect on the ability of PP1 tocritical for binding. As expected, pools with degenerate
amino acids in position 23, 22, and 12 were weaker dephosphorylate Raf-1.
inhibitors of binding, confirming that these are the criti-
cal positions. Phosphopeptides Can Inhibit
14-3-3/Raf-1 Interactions
As 14-3-3 binds Raf-1 constitutively in vivo, it was ofOther Isoforms Bind Phosphoserine with
the Same Affinity and Specificity interest to determine whether the Raf-1 phosphopep-
tides could inhibit the formation of 14-3-3/Raf-1 com-There are seven known isoforms of 14-3-3 that form
homo- and heterodimers in vivo (Jones et al., 1995). If plexes in vitro. Immobilized 14-3-3z was incubated with
either the unphosphorylated or phosphorylated pS-Raf-different isoforms of 14-3-3 could bind to proteins with
distinct specificities, heterodimeric forms of 14-3-3 259 peptide. Lysates from NIH 3T3 cells were then
incubated with the immobilized 14-3-3z and tested formight function as modular linker proteins, bringing to-
gether different proteins into a single complex. We were association of Raf-1. Incubation of 14-3-3z with the
phosphorylated Raf-259 peptide (pS-Raf-259) com-therefore interested in determining whether different 14-
3-3 isoforms recognize phosphoserine in a sequence- pletely inhibited its ability to bind Raf-1 (Figure 4A, lane
4). In contrast, incubation of cell lysates with the unphos-specific fashion. This hypothesis was tested by express-
ing and purifying three other 14-3-3 isoforms, h, b, and phorylated Raf-1 peptide had no effect on the ability of
14-3-3z to bind to full-length Raf-1 (Figure 4A, lane 3).t, and measuring their affinity toward the panel of phos-
phorylated peptides generated above. Using SPR, the The phosphopeptide could also promote the disasso-
ciation of preformed 14-3-3/Raf-1 complexes. We testedon and off rates for 14-3-3 binding to the phosphorylated
Raf-259 peptide (Figure 2B) were calculated. All four this by adding unphosphorylated and phosphorylated
Raf-259 peptides to cell lysates and immunoblottingisoforms demonstrated very similar apparent binding
14-3-3 Is a Phosphoserine-Binding Protein
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Figure 4. Serine Phosphorylated Peptide Inhibits 14-3-3/Raf-1
Figure 3. 14-3-3 Inhibits Dephosphorylation of Raf-1 Complexes
(A) Immobilized GST-Raf fusion protein was phosphorylated using (A) Phosphorylated Raf-259 peptide inhibits complex formation in
the catalytic subunit of PKA and incubated without (2) or with (1) vitro. Lysates prepared from NIH 3T3 cells were incubated with
10 mg GST/14-3-3b or GST-p56lck SH2. PP1 was added as desig- immobilized 14-3-3 in the presence or absence of phosphorylated
nated and incubated for 1 hr at 378C. Reactions were separated on and unphosphorylated Raf-1 peptides. After washing, Raf-1 binding
a 10% acrylamide SDS gel and analyzed by autoradiography. Arrow was analyzed by immunoblotting using a polyclonal anti-Raf-1 anti-
denotes GST-Raf fusion protein. body. Lane 1, lysate added to immobilized 14-3-3 in the absence
(B) Phosphorimager quantitation of results depicted in (A). of added peptide. Lane 2, lysate added to GST alone immobilized
on glutathione-agarose. Lane 3, lysate added to immobilized 14-
3-3 in the presence of unphosphorylated Raf-259 (10 mM) peptide.Raf-1 immunoprecipitates for associated 14-3-3. Addi-
Lane 4, lysate added to immobilized 14-3-3 in the presence of phos-
tion of the pS-Raf-259 peptide at either 10 mM or 100 phorylated pS-Raf-259 (10 mM) peptide.
mM disassociated Raf-1/14-3-3 complexes (Figure 4B, (B) Phosphorylated Raf-259 peptide can disrupt preexisting Raf-1/
lanes 2 and 3). Incubation of cell lysates with the unphos- 14-3-3 complexes. Phosphorylated or unphosphorylated Raf-259
peptide was added to cell lysates prepared from a mouse T cellphorylated Raf-259 peptide had no effect on Raf-1/14-
hybridoma. Raf-1 immunoprecipitates were separated by SDS±3-3 complexes (Figure 4B, lane 1). 14-3-3/Raf-1 com-
PAGE and analyzed by immunoblotting using an anti-14-3-3 poly-plexes can therefore be disassociated by incubation
clonal antibody. Lane 1, unphosphorylated Raf-259 peptide (100with the phosphorylated Raf-1 peptide.
mM) was added to cell lysate. Lane 2, phosphorylated pS-Raf-259
To test the functional role of 14-3-3 invivo, phosphory- peptide (10 mM) was added to cell lysate. Lane 3, phosphorylated
lated Raf-1 peptides were microinjected into frog oo- pS-Raf-259 peptide (100 mM) was added to cell lysate. Key: ab,
antibody.cytes. Because microinjection of 14-3-3 protein into frog
oocytes activates Raf-1 inducing oocyte maturation
(Fantl et al., 1994), we reasoned that inhibition of 14-
3-3 interactions using the phosphorylated Raf-1 pep- These results demonstrate that serine-phosphorylated
Raf-1 peptides can inhibit oocyte maturation, sug-tides should block Raf-1 activation and subsequent oo-
cyte maturation. Insulin was used to stimulate oocyte gesting that 14-3-3/Raf-1 complexes are required.
These results were confirmed by measuring Raf-1 ki-maturation, and maturation was measured by assessing
germinal vesicle breakdown (GVBD; Fabian et al., 1993; nase activity in the insulin-treated oocytes. Raf immuno-
precipitates from oocytes microinjected with the phos-Muslin et al., 1993). In the presence of insulin, microin-
jection of the phosphorylated but not the unphosphory- phorylated Raf-1 peptide, pS-Raf-259, demonstrated
little to no activation of Raf-1 kinase as compared withlated Raf-259 peptide inhibited insulin-stimulated GVBD
(Figure 5A). Consistent with this result, injection of the the oocytes mock injected or injected with the unphos-
phorylated Raf-1 peptide after insulin treatment. ThesepS-Raf-621 peptide significantly inhibited insulin-stimu-
lated GVBD, but the RA peptide did not (data not shown). results support previous work demonstrating that 14-
Cell
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Table 2. List of Proteins Known to Bind 14-3-3 with Alignment
of Their Putative Binding Sites
Raf-1 (254±261) RSTSTP
Raf-1 (616±623) RSASEP
B-RAF (241±248) RSSSAP
B-RAF (605±612) RSASEP
Polyoma middle T (268±275) RSHSYP
CDC25B (301±308) RSPSMP
PKC e (343±348) RSKSAP
PKC g (686±691) RSPSSP
BCR (368±373) RSQSQN
Tyrosine hydroxylase (266±271) RHASSP
similar to phosphorylated tyrosine residues as recogni-
tion sites for specific binding proteins (Pendergast et
al., 1991; Chrivia et al., 1993; Cleghon and Morrison,
1993).
Comparison of proteins known to bind 14-3-3 demon-
strated that many contain sequences similar to those
surrounding serine 259 of Raf-1. This analysis allowed
us to deduce a putative motif, RSxSxP for 14-3-3 bind-
ing. The integrity of this derived motif was tested by
using a series of alanine-substituted phosphorylated
peptides and a panel of degenerate peptides, as well
as by testing whether 14-3-3 could bind to a peptide
from a predicted site. The carboxy-terminal proline and
Figure 5. Serine-Phosphorylated Peptide Inhibits Xenopus Oocyte the amino-terminal arginine residues were important for
Maturation
binding. Although analysis of the position dependence
(A) Phosphorylated Raf-259 peptide inhibits germinal vesicle break-
of the arginine demonstrated high affinity binding in ei-down (GVBD) in Xenopus oocytes. Immature Xenopus oocytes were
ther the 23 and 24 positions, the 23 position is requiredmicroinjected with water or with 50 nmol of phosphorylated or un-
for phosphorylation by protein kinases. We suspectphosphorylated Raf-259 peptide. Some injected oocytes were stim-
ulated with 8.25 mg/ml of insulin (1) and observed for 24 hr. Oocytes therefore that arginine in the 23 position is the critical
were evaluated for the appearanceof a white spot onthe animal pole determinant for 14-3-3 binding in vivo.
(GVBD). Key: pS-259, phosphorylated pS-Raf-259 peptide; unphos- The inability of the doubly phosphorylated peptide,
259, unphosphorylated Raf-259 peptide.
pS-Raf-257,259, to bind 14-3-3 suggested that the ser-(B) Phosphorylated Raf-259 peptide inhibits insulin-induced Raf-1
ine residue in the 22 position may also be important.activation. Immature oocytes were injected with phosphorylated or
Experiments with degenerate peptides confirmed thatunphosphorylated peptide as above. Oocytes were stimulated with
insulin for 24 hr and protein lysates were made. Raf-1 immunopre- specificity is conferred by residues in the 22 as well as
cipitates were analyzed for Raf-1 kinase activity using recombinant the 23 and 12 positions relative to the phosphoserine.
polyhistidine-tagged MEK as a substrate. Lane 1, unstimulated wa- It will be important to determine whether other residues
ter-injected oocytes. Lane 2, insulin-stimulated water-injected oo-
can substitute for the arginine, serine, and proline. Thiscytes. Lane 3, insulin-stimulated phosphorylated pS-Raf-259 pep-
seems likely, as other proteins known to bind 14-3-3,tide injected oocytes. Lane 4, insulin-stimulated unphosphorylated
like bcr and tyrosine hydroxylase, contain related se-Raf-259 peptide injected oocytes.
quences (Table 2) but do not contain the exact motif.
An improved definition of the motif will be critical in the
identification of putative 14-3-3 binding proteins.3-3 is required for Raf-1 activation (Freed et al., 1994;
Our data suggests that other proteins containing theIrie et al., 1994; Li et al., 1995).
motif, if appropriately phosphorylated, might bind 14-
3-3. We therefore searched the SWISS-PROT protein
database for eukaryotic proteins that contain the se-Discussion
quence RSxSxP. As expected, c-Raf-1, CDC25, and
polyoma middle T antigen were identified. KinasesWe have determined that 14-3-3 is a sequence-specific
phosphoserine-binding protein. 14-3-3 binds to Raf-1 closely related to c-Raf-1, like A-Raf-1, B-Raf-1, mos,
mil, and MEKK also contain the motif. Some additionalpeptides representing two major serine phosphorylation
sites of Raf-1, serine 259 and serine 621. Using a variety proteins that contain the motif are shown in Table 3. We
are currently attempting to determine whether any ofof methods including surface plasmon resonance and
peptide competition, we determined that 14-3-3 binds these additional proteins associate with 14-3-3 in vivo.
to these phosphoserine peptides with high affinity. The
binding also appears to be sequence specific. Particu- The Role of 14-3-3 as a Scaffolding Protein
Members of the 14-3-3 family form homo- and hetero-larly compelling was our demonstration that peptides
phosphorylated on serine 257 instead of serine 259 had dimers in vivo and in vitro (Jones et al., 1995). Dimeriza-
tion of 14-3-3 could generate a protein with two ligand-no apparent affinity toward 14-3-3. Our results suggest
that phosphorylated serine residues may play a role binding sites. One function of 14-3-3 might be to bring
14-3-3 Is a Phosphoserine-Binding Protein
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Table 3. List of Predicted 14-3-3 Binding Proteins with activity. 14-3-3 might function as a chaperone to pro-
Alignment of Their Putative Binding Sites mote or stabilize an activatable conformation of Raf-1
as proposed by Morrison (1994). This explains why dis-A-RAF (206±213) RSTSTP
A-RAF (574±581) RSASEP ruption of the 14-3-3/Raf-1 complexes with the phos-
Bad RSRSAP phorylated peptide blocked Raf-1 activation. Still, 14-
Mos RSCSIP 3-3 interactions with phosphorylated serine 259 after
CDC25C RSPSMP
growth factor treatment may also be important, as serineGlucocorticoid receptor RSTSRP
259 is required for PKC activation of Raf-1 (Kolch et al.,KSR-1 RSPSFP
1993).PLC g RSESSP
p85 subunit of PI-3 kinase RSPSIP It is interesting to speculate that 14-3-3 interacts with
PTP-MEG RSPSKP many other proteins in the cell to perform an essential
PTP-epsilon RSPSGP chaperone function. Such a role would be consistent
PTP-mu RSVSSP
with its ubiquitous pattern of expression and its abun-SNF1 RSRSYP
dance in most cell types. The interaction of cytoplasmic59 AMP kinase RSQSKP
enzymes such as Raf-1 and c-src with heat shock pro-
Alignment of 14-3-3 binding motifs from proteins predicted to bind
teins (Stancato et al., 1993; Xu and Lindquist 1993),14-3-3. The SWISS±PROT database was searched with the se-
suggests that the folding, assembly, and transport ofquence RSxSxP using the pattern-match algorithm in the Gene-
cytoplasmic proteins will be regulated in a fashion simi-works software program (Intelligenetics). An alignment of the motif
from a selected group of proteins identified with the motif is shown. lar to that for proteins that enter the secretory pathway.
Whatever the case, our results demonstrate that the
function of 14-3-3 will be mediated via its recognition
together specific proteins in a phosphoserine-regulated of phosphoserine, suggesting a novel role for phospho-
manner. This model would be particularly attractive if serine as a recognition site for a binding protein and the
each of the 14-3-3 isoforms had specificity for distinct creation of multisubunit signaling complexes. Further-
phosphoserine sequences. We were, however, unable more, our results suggests that phosphoserine may play
to demonstrate any isoform specificity of 14-3-3 binding a role analogous to glycosylation, regulating protein
toward the panel of phosphorylated Raf-1 peptides. This folding and/or targeting in the cell.
finding is consistent with the structural features of 14-
3-3. Recently, crystallization of 14-3-3 revealed that the
Experimental Procedures
dimeric molecule has a cup-like shape (Liu et al., 1995;
Xiao et al., 1995). Most of the conserved residues of 14- Expression and Purification of 14-3-3 Fusion Proteins
3-3 line the inner, concave surface. It is therefore not GST/14-3-3 fusion proteins were created by generating BamHI and
EcoRI restriction sites at the 59 and 39 ends, respectively, of the 14-surprising that the specificity of peptides interacting
3-3 cDNAs by polymerase chain reaction (PCR). The cDNA productswith 14-3-3 are similar. An interaction of arginine- and
were subcloned into the vector pGEX-KT and purified as describedphosphoserine-containing peptides with the inner sur-
(Guan and Dixon1991). Protein was quantitated by Coomassie stain-
face of 14-3-3 is also consistent with the fact that the ing SDS-polyacrylamide gels compared against bovine serum albu-
inner surface is generally acidic with a small cluster of min standards.
basic residues at one corner of thesurface. It is possible,
however, that isoform-specific differences in phospho- Peptides
serine binding are subtle and were missed in the assays Peptides were synthesized, purified, and analyzed as previously
we performed. described (Lorenz et al., 1988). The peptides were synthesized on
either an ABI model 432A (Perkin/Elmer, Foster City, CA) or a Sym-
phony/Multiplex synthesizer (Rainin Instrument Co., Woburn, MA)The Role of 14-3-3 in Raf-1 Activation
using standard FMOC chemistry. The phosphoserine containingBased on our results, we believe that the primary 14-
peptides were synthesized as above using FMOC-Ser(PO(OH,3-3 binding site on Raf-1 is not Ser-259 as proposed
OBzl))-OH (NOVAbiochem, San Diego, CA) following themanufactur-
previously (Michaud et al, 1995), but rather Ser-621. Ser- er's recommendations. All other reagents for peptide synthesis were
259 phosphorylation is induced only after growth factor purchased from ABI, Rainin, and Advanced ChemTech (Louisville,
KY). The peptides were purified by C18 reverse-phase high pressurestimulation, but 14-3-3 is bound constitutively to Raf-1
liquid chromatography and their identify confirmed and their con-in unstimulated cells (Li et al., 1995; Dent et al., 1995).
centration determined by amino acid analysis (Beckman ModelTherefore, Ser-259 cannot be the primary binding site
6300, Beckman Instruments, Palo Alto, CA). All peptides were shown
in vivo. We believe that Ser-621, a Raf-1 site which is to consist of a single species of the correct molecular weight by
constitutively phosphorylated (Morrison et al., 1993), is mass spectrometry (Washington University Mass Spectrometry Fa-
probably the major 14-3-3 binding site in vivo. Michaud cility).
and coworkers suggested serine 259 as the major bind-
ing site, because baculovirus-expressed protein con- Peptide Binding Experiments
tains phosphorylation of both serine 259 and serine 621 The peptide (50 mM) was phosphorylated using protein kinase A
following the manufacturers instruction (PKA, New England Biolabs)(Morrison et al., 1993).
with 20 mCi of [g-32P]ATP (NEN±Du Pont, 6000 Ci/mmol). The stoichi-Binding of 14-3-3 does not directly activate Raf-1 per
ometry of phosphorylation (7%±12%) was calculated from the spe-se, as Raf-1/14-3-3 complexes are present in unstimu-
cific activity of the labeled peptide. For binding experiments, 300±lated cells (Li et al., 1995). But mutation of serine 621
500 ng of fusion protein was incubated with 1 mM labeled peptide
in Raf-1 inhibits the association of 14-3-3 (Michaud et on ice for 30 min in detergent buffer (1% Triton X-100 in phosphate-
al., 1995) and renders the kinase inactive. 14-3-3 binding buffered saline, 25 mM NaF, 100 mM orthovanadate, aprotinin). Pep-
tide competitors were preincubated with the protein for 5 min beforeto serine 621 may therefore be required for Raf-1 kinase
Cell
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addition of the labeled peptide (final concentration, 1 mM). Com- Raf-1 Kinase Assay
Xenopus oocytes were lysed as described previously (Muslin et al.,plexes were isolated using glutathione agarose beads and washed
extensively with detergent buffer before scintigraphy. Unphosphor- 1993). Raf-1 immunoprecipitates were washed and then incubated
in kinase buffer in the presence of 100 ng MEK and [g-32P]ATP asylated peptides used as competitors were prepared similarly to the
phosphorylated peptides, except that PKA was not added. The described (MacNicol et al., 1995). The samples were subjected to
SDS±PAGE. The phosphorylated substrate was visualized by auto-phosphorylated ETEE peptide was prepared using casein kinase II,
and substrate peptide (New England Biolabs). radiography.
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